XML 27 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity
3 Months Ended
Mar. 31, 2012
Stockholders Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
NOTE 10– STOCKHOLDERS’ EQUITY
 
(a)    Preferred stock issued for warrants modification
On February 7, 2012, in an effort to induce its warrant holder to exercise their warrants, the Company signed an agreement with Barron Partners LP (“Barron”), pursuant to which Barron, as the holder of warrants to purchase 55,158 shares of common stock at $12.00 per share and 165,000 shares of common stock at $16.98 per share, agreed to exchange or convert such warrants into (i) 2,201,582 shares of the Company’s series A preferred stock which are convertible into 73,386 shares of common stock, and (ii) warrants to purchase 73,386 shares of this Company’s common stock at $2.70 per common share, with the proceeds from the exercise of the warrants being used to pay expenses incurred by the Company in connection with its public company expenses. In connection with the warrant modification, the Company valued the 2,201,582 series A preferred shares issued at fair market value on the date of grant of $197,408 based on the 73,386 common shares issuable upon conversion of the series A preferred stock multiplied by the quoted trading price of the common stock on the grant date of $2.70 per share.  In connection with the transaction, on February 7, 2012, we revalued the fair market value of the original warrants by using the Black-Scholes option-pricing model.    The total fair market value of the original warrants was estimated to be $52,896 on February 7, 2012. The fair market value of the newly issued exchanged warrants was estimated to be $90,621 using the Black-Scholes option-pricing model.  In connection with the Black-Scholes option pricing calculation, the following weighted-average assumptions were used:  stock price of $2.70; expected dividend yield 0%; risk-free interest rate of 0.15%; volatility of 139.58% and an expected term of 0.77 year. We recorded the difference between the fair market value of original warrants of $52,896 and the fair market value of exchanged warrants of $90,621 which amounted to $37,725 as a warrants modification expense with a corresponding credit of additional paid-in capital.
 
Accordingly, for the three months ended March 31, 2012, the Company recorded an aggregate warrant modification expense of $235,133 on the accompanying consolidated statement of income.
 
(b)    Common stock issued for services
 
During the three months ended March 31, 2012, the Company issued a total of 39,450 shares of common stock pursuant to its 2010 long-term incentive plan, of which 250 shares were issued to a director, 10,000 shares were issued to the chief executive officers and 29,200 shares were issued to other employees and consultants.  The shares were valued at the fair market value on the date of grant.  During the three months ended March 31, 2012, the Company record stock-based compensation of $28,190 and prepaid expense of $82,320, which is being amortized over the balance of 2012.
 
(c)    Common stock issued for preferred share conversions
 
During the three months ended March 31, 2012, the Company issued 152,723 shares of common stock upon the conversion of 4,581,719 shares of series A preferred stock.
 
(d)    Warrants
 
Warrant activity for the three months ended March 31, 2012 is summarized as follows:
 
   
Three Months Ended March 31, 2012
 
   
Number of Warrants
   
Weighted Average
Exercise Price
 
Balance at December 31, 2011
    220,158     $ 15.73  
Granted
    73,386       2.70  
Exercised
    -       -  
Cancelled
    (220,158 )     (15.73 )
Balance at March 31, 2012
    73,386     $ 2.70  
Warrants exercisable at March 31, 2012
    73,386     $ 2.70  
 
(d)    Warrants
 
The following table summarizes the shares of the Company's common stock issuable upon exercise of warrants outstanding at March 31, 2012:
 
Warrants Outstanding
   
Warrants Exercisable
 
Range of Exercise Price
   
Number Outstanding at
March 31, 2012
   
Weighted Average Remaining Contractual Life (Years)
   
Weighted Average
Exercise Price
   
Number
Exercisable at
March 31, 2012
   
Weighted Average
Exercise Price
 
$ 2.70       73,386       0.62     $ 2.70       73,386     $ 2.70